Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock - $0.001 par value
-
Shares outstanding
-
10,630,964
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
458,415
-
Shares change
-
+567
-
Total reported value, excl. options
-
$4,562,000
-
Value change
-
+$176,424
-
Number of buys
-
7
-
Number of sells
-
4
-
Price
-
$9.95
Institutional Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q4 2019
As of 31 Dec 2019 NEPHROS INC - Common Stock - $0.001 par value (NEPH) had 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 458,415 shares of stock of the company.
Largest 10 holders included Parkman Healthcare Partners LLC, INGALLS & SNYDER LLC, HighTower Advisors, LLC, BLAIR WILLIAM & CO/IL, MILLENNIUM MANAGEMENT LLC, National Asset Management, Inc., ELKHORN PARTNERS LIMITED PARTNERSHIP, BlackRock Inc., UBS Group AG, and PRELUDE CAPITAL MANAGEMENT, LLC.
This table shows 15 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.